Purchase Order N6264521P0002
Award Date 12/1/20
Potential Completion Date 11/30/25
Potential Value $847K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order awarded by the Defense Health Agency, a component of the Department of Defense, to Fenwal, Inc., a global blood technology company and a subsidiary of Fresenius Kabi. The $1,569.00 contract is for the delivery of various blood collection, separation, storage, and transfusion products, including blood bags, tubing, diluting solutions, washing solutions, anticoagulants, extractors, sealers, clips, stands, and transfer sets. Fenwal, Inc. has an extensive...
- This is a $177,697.86 firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Fenwal, Inc., a foreign-owned for-profit manufacturer of medical products. The contract is for the delivery of BLOOD BAGS and is set aside for small businesses. Fenwal, a subsidiary of Fresenius Kabi, is a global blood technology company that has received numerous federal contracts to provide products and services related to blood collection,...
- This federal contract award from the Defense Logistics Agency (DLA) is for the provision of blood collection supplies to support medical and healthcare initiatives. The $5,743.25 firm-fixed-price purchase order was awarded to Fenwal, Inc., a foreign-owned, for-profit manufacturer of blood collection, separation, storage, and transfusion products and services. The contract has a performance period ending on March 26, 2025 and does not include a set-aside designation. Fenwal, Inc. is a key...
- This is a firm-fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Fenwal, Inc., a subsidiary of Fresenius Kabi, to provide blood bags for the military. The contract has a potential value of $100,519.90 and a completion date of August 31, 2022. Fenwal is a global blood technology company that has received numerous federal contract awards as a prime contractor to provide blood collection, separation, storage, and transfusion...
- This is a $21,400 firm-fixed-price purchase order awarded to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, by the Defense Health Agency. The contract is for the supply of various medical supplies and equipment to support transfusion medicine and cell therapy applications, including blood bags, tubing, solutions, apheresis equipment, and other specialized items used in blood banking and biomedical research operations. The award does not have a set-aside...
- The U.S. Defense Department's Medical Supply Chain, through its Defense Logistics Agency, awarded a $1,148.65 firm fixed-price purchase order to Fenwal, Inc. for blood collection assemblies. The contract, issued on September 16, 2025, with an ultimate completion date of September 22, 2025, carries no set-aside designation and represents a competitive award to the prime contractor. Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi headquartered in Lake Zurich,...
- The Defense Logistics Agency Troop Support Medical has awarded Fenwal, Inc., a Fresenius Kabi company, a $1,062.50 firm-fixed-price purchase order for blood collection products and services. Fenwal, a global blood technology company, will provide items such as blood bags, tubing, solutions, and equipment to support the U.S. military's blood program and federal biomedical research. This contract was awarded without a set-aside designation due to Fenwal's specialized capabilities as a manufacturer...
- The Defense Health Agency awarded a firm fixed-price purchase order to Fenwal, Inc. on December 1, 2025, for the supply of frozen blood, blood collection bags, and glycerolyte 57% solutions. The contract, valued at $237,718.20 with an ultimate completion date of September 30, 2026, will be performed at Camp Lejeune, North Carolina. This award carries no set-aside designation, reflecting Fenwal's specialized capabilities as the sole source provider for these critical blood banking consumables and...
- This is a definitive contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Fenwal, Inc., a global blood technology company, for the procurement of blood collection bags. The contract has a firm fixed price, a ceiling value of $911,730.34, and an ultimate completion date of September 30, 2020. Fenwal, Inc. has been a registered vendor with the U.S. federal government since 2007 and has established itself as a key supplier to various federal...
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, located in Lake Zurich, Illinois. The contract is for the supply of a blood pack with an anticoagulant, with a ceiling value of $1,101.28 and an ultimate completion date of August 4, 2025. The contract does not have a set-aside designation. Fenwal, Inc. is a registered vendor with the U.S. federal government,...